Bessemer Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
Bessemer Group's LKFT Position: Q3 2026 in Review
Bessemer Group held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q3 2026 at 108 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #2349.
Bessemer Group first reported a position in LKFT in Q2 2019 and has held it in 11 quarters since. The position peaked at $56.1M in Q4 2019. 67 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.
- Bessemer Group held 108 shares of Lakefront Biotherapeutics American Depositary Shares worth $3K as of Q3 2026.
- Bessemer Group left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q3 2026.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #2349 holding.
- Bessemer Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2019 and has held it in 11 quarters since.
- Bessemer Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $56.1M in Q4 2019.
- 67 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.
Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.